Very early molecular marker of tumor response to PD-1 inhibition in plasma of patients with advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Hiltermann, Thijo Jeroen Nicolaas
Miedema, A.
Hijmering-Kappelle, Lucie
Groen, Harry J. M.
Schuuring, Ed
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3030
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC).
    Luo, Jia
    Bandlamudi, Chaitanya
    Ricciuti, Biagio
    Vokes, Natalie
    Schoenfeld, Adam Jacob
    Egger, Jacklynn, V
    Sauter, Jennifer L.
    Plodkowski, Andrew J.
    Preeshagul, Isabel Ruth
    Kris, Mark G.
    Van Allen, Eliezer Mendel
    Taylor, Barry S.
    Rizvi, Hira
    Donoghue, Mark
    Awad, Mark M.
    Hellmann, Matthew David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Evaluation of PD-L1/PD-1 on circulating tumor cells (CTCs) and on primary tumor in advanced non-small cell lung cancer (NSCLC)
    Kallergi, Galaktea
    Vetsika, Eleni Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    CANCER RESEARCH, 2017, 77
  • [3] Pre-Treatment Tumor Volume in Non-Small Cell Lung Cancer (NSCLC) as a Predictor of Response to PD-1 Inhibitors
    Nagasaka, M.
    Crosby, M.
    Thummala, N.
    Abrams, J.
    Sukari, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2431 - S2431
  • [4] Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer
    Di Huang
    Fan Zhang
    Haitao Tao
    Sujie Zhang
    Junxun Ma
    Jinliang Wang
    Zhefeng Liu
    Pengfei Cui
    Shixue Chen
    Ziwei Huang
    Zhaozhen Wu
    Lei Zhao
    Yi Hu
    Targeted Oncology, 2020, 15 : 93 - 100
  • [5] Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer
    Huang, Di
    Zhang, Fan
    Tao, Haitao
    Zhang, Sujie
    Ma, Junxun
    Wang, Jinliang
    Liu, Zhefeng
    Cui, Pengfei
    Chen, Shixue
    Huang, Ziwei
    Wu, Zhaozhen
    Zhao, Lei
    Hu, Yi
    TARGETED ONCOLOGY, 2020, 15 (01) : 93 - 100
  • [6] Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
    Kallergi, Galatea
    Vetsika, Eleni-Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Messaritakis, Ippokratis
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [7] Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patients
    Kamphorst, Alice O.
    Pillai, Rathi N.
    Yang, Shu
    Akondy, Rama
    Koenig, Lydia
    Yu, Ke
    McCausland, Megan
    Sica, Gabriel
    Khuri, Fadlo R.
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Ahmed, Rafi
    CANCER RESEARCH, 2015, 75
  • [8] Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients
    Mathew, Divij
    Marmarelis, Melina E.
    Foley, Caitlin
    Bauml, Joshua M.
    Ye, Darwin
    Ghinnagow, Reem
    Ngiow, Shin Foong
    Klapholz, Max
    Jun, Soyeong
    Zhang, Zhaojun
    Zorc, Robert
    Davis, Christiana W.
    Diehn, Maximillian
    Giles, Josephine R.
    Huang, Alexander C.
    Hwang, Wei-Ting
    Zhang, Nancy R.
    Schoenfeld, Adam J.
    Carpenter, Erica L.
    Langer, Corey J.
    Wherry, E. John
    Minn, Andy J.
    SCIENCE, 2024, 384 (6702) : 1314 - +
  • [9] Is checkpoint inhibitor pneumonitis underreported in patients with advanced non-small cell lung cancer (NSCLC) on PD-1 inhibitor monotherapy?
    Spieler, Benjamin Oren
    Lopes, Gilberto
    Dal Pra, Alan
    Diwanji, Tejan
    Yechieli, Raphael
    Freedman, Laura M.
    Mihaylov, Ivaylo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer
    Dan, Asaf
    Aricak, Ozan
    Rounis, Konstantinos
    Montero-Fernandez, M. Angeles
    Guijarro, Ricardo
    Ekman, Simon
    Ortiz-Villalon, Cristian
    De Petris, Luigi
    FRONTIERS IN ONCOLOGY, 2024, 14
12345